Art. 23 Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

Comparative assessment of biocidal products

In forcesince 25 Apr 2014cited 34×
1.

The receiving competent authority or, in the case of an evaluation of an application for a Union authorisation, the evaluating competent authority, shall perform a comparative assessment as part of the evaluation of an application for authorisation or for renewal of authorisation of a biocidal product containing an active substance that is a candidate for substitution in accordance with Article 10(1).

2.

The results of the comparative assessment shall be forwarded, without delay, to the competent authorities of other Member States and the Agency and, in the case of evaluation of an application for a Union authorisation, also to the Commission.

3.

The receiving competent authority or, in the case of a decision on an application for a Union authorisation, the Commission, shall prohibit or restrict the making available on the market or the use of a biocidal product containing an active substance that is a candidate for substitution where a comparative assessment, performed in accordance with the technical guidance notes referred to in Article 24, demonstrates that both of the following criteria are met:

(a)

for the uses specified in the application, another authorised biocidal product or a non-chemical control or prevention method already exists which presents a significantly lower overall risk for human health, animal health and the environment, is sufficiently effective and presents no other significant economic or practical disadvantages;

(b)

the chemical diversity of the active substances is adequate to minimise the occurrence of resistance in the target harmful organism.

4.

By way of derogation from paragraph 1, a biocidal product containing an active substance that is a candidate for substitution may be authorised for a period of up to four years without comparative assessment in exceptional cases where it is necessary to acquire experience first through using that product in practice.

5.

Where the comparative assessment involves a question which, by reason of its scale or consequences, would be better addressed at Union level, in particular where it is relevant to two or more competent authorities, the receiving competent authority may refer the question to the Commission for a decision. The Commission shall adopt that decision by means of implementing acts in accordance with the examination procedure referred to in Article 82(3).

The Commission shall be empowered to adopt delegated acts in accordance with Article 83 specifying the criteria for determining when comparative assessments involve questions better addressed at Union level and the procedures for such comparative assessments.

6.

Notwithstanding Article 17(4), and without prejudice to paragraph 4 of this Article, an authorisation for a biocidal product containing an active substance that is a candidate for substitution shall be granted for a period not exceeding five years and renewed for a period not exceeding five years.

7.

Where it is decided not to authorise or to restrict the use of a biocidal product pursuant to paragraph 3, that cancellation or amendment of the authorisation shall take effect four years after that decision. However, where the approval of the active substance which is a candidate for substitution expires on an earlier date, the cancellation of the authorisation shall take effect on that earlier date.

The 10 that are cited most themselves, of 34.

  • Regulation (EU) 2015/1759Law

    По смисъла на член 23 от Регламент (ЕС) № 528/2012 обаче глутаралдехид изпълнява условията по член 10, параграф 1, буква б) от същия …

  • Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and char…Law

    … | 47800 Redevance supplémentaire par produit dans le cas où une évaluation comparative conformément à l’article 23 du règlement (UE) no 528/2012 est nécessaire | 47800 Redevance supplémentaire par produit dans le cas où …

  • Regulation (EU) 2015/985Law

    По смисъла на член 23 от Регламент (ЕС) № 528/2012 обаче клотианидин изпълнява условията по член 10, параграф 1, буква г) от същия …

  • Regulation (EU) 2015/416Law

    … Daher sollte Dinotefuran für die Zwecke der Zulassung von Produkten gemäß Artikel 23 der Verordnung (EG) Nr. 528/2012 als zu ersetzender Wirkstoff im Sinne von Artikel 10 Absatz 1 Buchstabe d der Verordnung angesehen werden.

  • Decision_act (EU) 2024/8161Law

    … индентифицирани видове употреба, посочени в заявлението по член 23, параграф 3, буква а) от Регламент (ЕС) № 528/2012 („Регламента за …

  • Decision_act (EU) 2017/15321Law

    … въпроси в таблица 1 са изброени конкретните видове употреба по член 23, параграф 3, буква а) от Регламент (ЕС) № 528/2012. Номер на …

  • Code de l'environnementr522-8Law

    … effectue l'évaluation d'un dossier nécessitant la réalisation d'une évaluation comparative en application de l'article 23 du règlement (UE) n° 528/2012 du 22 mai 2012, l'Agence nationale communique au ministre chargé de …

  • Gesetz zum Schutz vor gefährlichen Stoffen12dLaw

    … 528/2012, 3. das Ergebnis einer vergleichenden Bewertung nach Artikel 23 der Verordnung (EU) Nr. 528/2012, 4. die Erteilung einer Zulassung nach Artikel 26 Absatz 3 der Verordnung (EU) Nr. 528/2012, 5. Ausnahmezulassungen nach Artikel 55 …

  • Regulation (EU) No 334/2014 of the European Parliament and of the Council of 11 March 20…Lawamends

  • Commission Delegated Regulation (EU) No 492/2014 of 7 March 2014 supplementing Regulatio…5Law

    … е постигнато споразумение. Без да се засягат разпоредбите на член 23, параграф 6 от Регламент (ЕС) № 528/2012, разрешенията се подновяват …